S. Amadori, R. Stasi, A. M. Martelli, A. Venditti, G. Meloni et al., Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107), British Journal of Haematology, vol.12, issue.2, pp.205-212, 2012.
DOI : 10.1111/j.1365-2141.2011.08940.x

C. Atkins, Q. Liu, E. Minthorn, S. Y. Zhang, D. J. Figueroa et al., Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity, Cancer Research, vol.73, issue.6, 1993.
DOI : 10.1158/0008-5472.CAN-12-3109

J. T. Babcock, H. B. Nguyen, Y. He, J. W. Hendricks, R. C. Wek et al., Mammalian Target of Rapamycin Complex 1 (mTORC1) Enhances Bortezomib-induced Death in Tuberous Sclerosis Complex (TSC)-null Cells by a c-MYC-dependent Induction of the Unfolded Protein Response, Journal of Biological Chemistry, vol.288, issue.22, pp.15687-15698, 2013.
DOI : 10.1074/jbc.M112.431056

F. Barabé, J. A. Kennedy, K. J. Hope, D. , and J. E. , Modeling the Initiation and Progression of Human Acute Leukemia in Mice, Science, vol.316, issue.5824, pp.600-604, 2007.
DOI : 10.1126/science.1139851

Y. V. Budovskaya, J. S. Stephan, F. Reggiori, D. J. Klionsky, and P. K. Herman, The Ras/cAMP-dependent Protein Kinase Signaling Pathway Regulates an Early Step of the Autophagy Process in Saccharomyces cerevisiae, Journal of Biological Chemistry, vol.279, issue.20, 2004.
DOI : 10.1074/jbc.M400272200

D. F. Calvisi, C. Wang, C. Ho, S. Ladu, S. A. Lee et al., Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma, Gastroenterology, vol.140, issue.3, pp.1071-1083, 2011.
DOI : 10.1053/j.gastro.2010.12.006

E. Campeau, V. E. Ruhl, F. Rodier, C. L. Smith, B. L. Rahmberg et al., A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells, PLoS ONE, vol.23, issue.1, p.6529, 2009.
DOI : 10.1371/journal.pone.0006529.s005

H. J. Clarke, J. E. Chambers, E. Liniker, and S. J. Marciniak, Endoplasmic Reticulum Stress in Malignancy, Cancer Cell, vol.25, issue.5, pp.563-573, 2014.
DOI : 10.1016/j.ccr.2014.03.015

B. Cool, B. Zinker, W. Chiou, L. Kifle, N. Cao et al., Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome, Cell Metabolism, vol.3, issue.6, pp.403-416, 2006.
DOI : 10.1016/j.cmet.2006.05.005

D. F. Egan, D. B. Shackelford, M. M. Mihaylova, S. Gelino, R. A. Kohnz et al., Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy, Science, vol.331, issue.6016, pp.456-461, 2011.
DOI : 10.1126/science.1196371

M. Elgendy, C. Sheridan, G. Brumatti, M. , and S. J. , Oncogenic Ras-Induced Expression of Noxa and Beclin-1 Promotes Autophagic Cell Death and Limits Clonogenic Survival, Molecular Cell, vol.42, issue.1, pp.23-35, 2011.
DOI : 10.1016/j.molcel.2011.02.009

B. Faubert, G. Boily, S. Izreig, T. Griss, B. Samborska et al., AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In??Vivo, Cell Metabolism, vol.17, issue.1, pp.113-124, 2013.
DOI : 10.1016/j.cmet.2012.12.001

M. D. Fullerton, S. Galic, K. Marcinko, S. Sikkema, T. Pulinilkunnil et al., Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin, Nature Medicine, vol.261, issue.12, pp.1649-1654, 2013.
DOI : 10.1111/j.1749-6632.1959.tb44923.x

B. Gan, J. Hu, S. Jiang, Y. Liu, E. Sahin et al., Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells, Nature, vol.105, issue.7324, pp.701-704, 2010.
DOI : 10.1038/nature09595

A. S. Green, N. Chapuis, T. T. Maciel, L. Willems, M. Lambert et al., The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation, Blood, vol.116, issue.20, pp.4262-4273, 2010.
DOI : 10.1182/blood-2010-02-269837

S. Gurumurthy, S. Z. Xie, B. Alagesan, J. Kim, R. Z. Yusuf et al., The Lkb1 metabolic sensor maintains haematopoietic stem cell survival, Nature, vol.11, issue.7324, pp.659-663, 2010.
DOI : 10.1038/nature09572

D. M. Gwinn, D. B. Shackelford, D. F. Egan, M. M. Mihaylova, A. Mery et al., AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint, Molecular Cell, vol.30, issue.2, pp.214-226, 2008.
DOI : 10.1016/j.molcel.2008.03.003

D. G. Hardie, F. A. Ross, and S. A. Hawley, AMPK: a nutrient and energy sensor that maintains energy homeostasis, Nature Reviews Molecular Cell Biology, vol.26, issue.4, pp.251-262, 2012.
DOI : 10.1038/nrm3311

H. P. Harding, Y. Zhang, D. Scheuner, J. J. Chen, R. J. Kaufman et al., Ppp1r15 gene knockout reveals an essential role for translation initiation factor 2 alpha (eIF2alpha) dephosphorylation in mammalian development, 2009.

K. Inoki, Y. Li, T. Zhu, J. Wu, and K. L. Guan, TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling, Nature Cell Biology, vol.4, issue.9, pp.648-657, 2002.
DOI : 10.1038/ncb839

K. Inoki, T. Zhu, and K. L. Guan, TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival, Cell, vol.115, issue.5, pp.577-590, 2003.
DOI : 10.1016/S0092-8674(03)00929-2

S. M. Jeon, N. S. Chandel, and N. Hay, AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress, Nature, vol.281, issue.7400, pp.661-665, 2012.
DOI : 10.1038/nature11066

L. Kamentsky, T. R. Jones, A. Fraser, M. A. Bray, D. J. Logan et al., Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software, Bioinformatics, vol.27, issue.8, pp.1179-1180, 2011.
DOI : 10.1093/bioinformatics/btr095

I. Kelsey and B. D. Manning, mTORC1 Status Dictates Tumor Response to Targeted Therapeutics, Science Signaling, vol.6, issue.294, p.31, 2013.
DOI : 10.1126/scisignal.2004632

M. G. Kharas, R. Okabe, J. J. Ganis, M. Gozo, T. Khandan et al., Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice, Blood, vol.115, issue.7, pp.1406-1415, 2010.
DOI : 10.1182/blood-2009-06-229443

J. Kim, M. Kundu, B. Viollet, and K. L. Guan, AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1, Nature Cell Biology, vol.4, issue.2, pp.132-141, 2011.
DOI : 10.1016/j.cub.2010.04.041

K. R. Laderoute, K. Amin, J. M. Calaoagan, M. Knapp, T. Le et al., 5'-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments, Molecular and Cellular Biology, vol.26, issue.14, pp.5336-5347, 2006.
DOI : 10.1128/MCB.00166-06

C. A. Lamb, T. Yoshimori, and S. A. Tooze, The autophagosome: origins unknown, biogenesis complex, Nature Reviews Molecular Cell Biology, vol.20, issue.12, pp.759-774, 2013.
DOI : 10.1038/nrm3696

B. Levine and G. Kroemer, Autophagy in the Pathogenesis of Disease, Cell, vol.132, issue.1, pp.27-42, 2008.
DOI : 10.1016/j.cell.2007.12.018

X. Liu, R. R. Chhipa, S. Pooya, M. Wortman, S. Yachyshin et al., Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK, Proceedings of the National Academy of Sciences, vol.111, issue.4, 2014.
DOI : 10.1073/pnas.1311121111

O. Mirguet and A. Bouillot, Patent WO 2011138307A1 Pyrrolo [3, 2 -d] pyrimidin-3 -yl derivatives used as activators of ampk, 2011.

M. Mizuki, R. Fenski, H. Halfter, I. Matsumura, R. Schmidt et al., Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways, Blood, vol.96, pp.3907-3914, 2000.

N. Mizushima, T. Yoshimori, and B. Levine, Methods in Mammalian Autophagy Research, Cell, vol.140, issue.3, pp.313-326, 2010.
DOI : 10.1016/j.cell.2010.01.028

D. Nakada, T. L. Saunders, and S. J. Morrison, Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells, Nature, vol.25, issue.7324, pp.653-658, 2010.
DOI : 10.1038/nature09571

U. Ozcan, E. Yilmaz, L. Ozcan, M. Furuhashi, E. Vaillancourt et al., Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes, Science, vol.313, issue.5790, pp.1137-1140, 2006.
DOI : 10.1126/science.1128294

U. Ozcan, L. Ozcan, E. Yilmaz, K. Dü-vel, M. Sahin et al., Loss of the Tuberous Sclerosis Complex Tumor Suppressors Triggers the Unfolded Protein Response to Regulate Insulin Signaling and Apoptosis, Molecular Cell, vol.29, issue.5, pp.541-551, 2008.
DOI : 10.1016/j.molcel.2007.12.023

A. E. Perl, M. T. Kasner, D. E. Tsai, D. T. Vogl, A. W. Loren et al., A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia, Clinical Cancer Research, vol.15, issue.21, pp.6732-6739, 2009.
DOI : 10.1158/1078-0432.CCR-09-0842

S. Scotland, E. Saland, N. Skuli, F. De-toni, H. Boutzen et al., Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells, Leukemia, vol.3, issue.11, pp.2129-2138, 2013.
DOI : 10.1038/leu.2013.107

D. B. Shackelford, D. S. Vasquez, J. Corbeil, S. Wu, M. Leblanc et al., mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome, Proc. Natl. Acad. Sci. USA, pp.11137-11142, 2009.

J. H. Sheen, R. Zoncu, D. Kim, and D. M. Sabatini, Defective Regulation of Autophagy upon Leucine Deprivation Reveals a Targetable Liability of Human Melanoma Cells In??Vitro and In??Vivo, Cancer Cell, vol.19, issue.5, pp.613-628, 2011.
DOI : 10.1016/j.ccr.2011.03.012

S. A. Stewart, D. M. Dykxhoorn, D. Palliser, H. Mizuno, E. Y. Yu et al., Lentivirus-delivered stable gene silencing by RNAi in primary cells, RNA, vol.9, issue.4, pp.493-501, 2003.
DOI : 10.1261/rna.2192803

X. Sui, R. Chen, Z. Wang, Z. Huang, N. Kong et al., Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment, Cell Death and Disease, vol.29, issue.10, p.838, 2013.
DOI : 10.1158/0008-5472.CAN-11-3396

H. Takeuchi, Y. Kondo, K. Fujiwara, T. Kanzawa, H. Aoki et al., Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors, Cancer Res, vol.65, pp.3336-3346, 2005.

J. Tamburini, A. S. Green, V. Bardet, N. Chapuis, S. Park et al., Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia, Blood, vol.114, issue.8, pp.1618-1627, 2009.
DOI : 10.1182/blood-2008-10-184515

P. Van-galen, A. Kreso, N. Mbong, D. G. Kent, T. Fitzmaurice et al., The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress, Nature, vol.397, issue.7504, pp.268-272, 2014.
DOI : 10.1038/nature13228

C. L. Vá-zquez and M. I. Colombo, Chapter 6 Assays to Assess Autophagy Induction and Fusion of Autophagic Vacuoles with a Degradative Compartment, Using Monodansylcadaverine (MDC) and DQ???BSA, Methods Enzymol, vol.452, pp.85-95, 2009.
DOI : 10.1016/S0076-6879(08)03606-9

Q. Wang, H. Mora-jensen, M. A. Weniger, P. Perez-galan, C. Wolford et al., ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells, Proc. Natl. Acad. Sci. USA, pp.2200-2205, 2009.
DOI : 10.1073/pnas.0807611106

D. Wiederschain, S. Wee, L. Chen, A. Loo, G. Yang et al., Single-vector inducible lentiviral RNAi system for oncology target validation, Cell Cycle, vol.8, issue.3, pp.498-504, 2009.
DOI : 10.4161/cc.8.3.7701

B. Xiao, M. J. Sanders, D. Carmena, N. J. Bright, L. F. Haire et al., Structural basis of AMPK regulation by small molecule activators, Nature Communications, vol.269, p.3017, 2013.
DOI : 10.1107/S0907444994003112

J. Yeung, M. T. Esposito, A. Gandillet, B. B. Zeisig, E. Griessinger et al., ??-Catenin Mediates the Establishment and Drug Resistance of MLL Leukemic Stem Cells, Cancer Cell, vol.18, issue.6, pp.606-618, 2010.
DOI : 10.1016/j.ccr.2010.10.032